The Endometrial Ablation Market was valued at US$ 3.2 Billion in 2022 and is expected to grow with a CAGR of 7.3% from 2023 to 2033. Increasing awareness about women’s health and endometrial ablation, the surge in demand for minimally invasive procedures, and the rising prevalence of menorrhagia are some of the factors that are expected to drive the endometrial ablation market during the forecast period. The market accounted for an absolute dollar opportunity of nearly US$ 3.4 Billion from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Endometrial Ablation Market (2023) | US$ 3.4 Billion |
| Global Endometrial Ablation Market (2033) | US$ 6.8 Billion |
| Global Endometrial Ablation Market CAGR (2023 to 2033) | 7.3% |
| USA Endometrial Ablation Market CAGR (2023 to 2033) | 6.3% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Endometrial Ablation Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around a CAGR of 5.9%. Growing with an absolute dollar opportunity of US$ 3.4 Billion from 2023 to 2033, the market is projected to reach US$ 6.8 Billion by 2033.
With the advent of minimally invasive endometrial ablation treatments, the endometrium can be destroyed in a more expedient, outpatient setting. This operation is less dangerous and technically straightforward to carry out.
The International Federation of Gynaecology and Obstetrics estimates that between 3% and 30% of reproductive-aged women are affected by Abnormal Uterine Bleeding. Women's treatment plans have become the key focus of the general health industry in the modern world. Governments and private organizations around the world have placed women's health at the center of their wellbeing race.
In India, such as in many other locations, women are eligible for several tax benefits and exemptions under the provisions of several sections of the tax code. Women's healthcare initiatives may promote the effectiveness of treatment alternatives, which will boost the market.
Principal Consultant
Asia Pacific has high women population, which makes it a lucrative destination for endometrial ablation. Growing health infrastructure and awareness about new women’s healthcare technologies are further expected to swell the demand for endometrial ablation procedures in the region. Furthermore, the market is expected to develop due to an increase in the prevalence of menorrhagia. In the past years, the availability of ambulatory surgery centers and improved endometrial ablation devices in clinics are driving the regional demand.
The market in the USA is expected to reach a valuation of US$ 1.8 Billion by 2033. Between 2023 and 2033, the market is expected to expand by US$ 807.5 Million in absolute dollars.
The market in the United kingdom is expected to reach a valuation of US$ 319.8 Million by 2033. Growing with a CAGR of 8.4% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 176 Million.
In Japan, the market is expected to grow at a CAGR of 9.2% from 2023 to 2033, reaching around US$ 360 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 210 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 179 Million by 2033, growing at a CAGR of 8.5% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 99 Million.
The rising healthcare expenditure in India has increased growth prospects for the endometrial ablation market in the coming future. As the prevalence of cancer rises in India, so does the demand for various radiation devices and procedures. Furthermore, the government in India is focusing on expanding access to modern and sophisticated healthcare services as well as improving reimbursement coverage. For example, between 2019 and 2020, India's healthcare spending grew from 1.2% to 2.5% of GDP, as the government expanded healthcare spending.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for radiation equipment has advanced significantly during the last decade. These advancements have contributed to the development of more effective, low-cost, and easy-to-use radiotherapy systems that offer enhanced and precise radiation doses, leading to increased tumor-targeting efficiency. With the move from 2D to 3D real-time imaging and planar radiotherapy, dose escalation with improved tumor control and enhanced conformance of radiation to the target growth in the near future, especially in mature markets where technologically advanced products are widely used.
Given these considerations, several market participants started to concentrate their efforts on the development, approval, and marketing of technologically upgraded products. In 2020, PMB, a part of the ALCEN Group, announced the launch of FLASHKNiFE, a FLASH radiation system specialized for clinical studies. In 2020, The Elekta Harmony linear accelerator was launched by Elekta, a system that can treat cancer with a 25% reduction in treatment time and a 30% reduction in footprint.
The goal of such technological improvements is to improve the functionality of radiation delivery systems while also broadening their application area. One of the primary factors driving the growth of the radiotherapy market is the increasing acceptance of these systems in various applications and settings.
In 2020, the hospital category accounted for a significant share due to an increase in the number of patients admitted to hospitals for gynecological issues. In addition, hospitals have advanced treatment devices, which helps in the segment's growth. Furthermore, hospitals experience a significantly higher influx of patients for gynecological treatments than other healthcare settings due to the convenience of handling any difficulties that may arise after surgical operations and the availability of a wide range of treatment alternatives in the facility.
The growth of the ablation technology market for surgical centers, hospitals, and ablation centers is fuelled by the rising prevalence of cancer, sports injuries, and heart problems.
The key players in the global endometrial ablation market are Medtronic, CooperSurgical Inc., Boston Scientific Corp., Ethicon, Inc., Olympus Corp., Richard Wolf GmbH, AngioDynamics, Hologic, Inc., and Minerva Surgical, Inc.
A few of the recent developments in the market are:
In 2023, the worldwide endometrial ablation market value could be around US$ 3.4 billion.
The overall market valuation is anticipated to reach nearly US$ 6.8 billion by 2033.
The United States leads the global market and could be valued at US$ 1.8 billion by 2033 end.
Japan at 9.2% CAGR may drive the regional Market through 2033.
Medtronic, CooperSurgical, and Boston Svientific are some top players in the market.
1. Executive Summary | Endometrial Ablation Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Future Market Insights Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Market (US$ Million)
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Market Growth
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Analysis, 2018 to 2022
6.2. Current and Future Market Projections, 2023 to 2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Type Technique, 2018 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type Technique, 2023 to 2033
8.3.1. Devices
8.3.1.1. Cryoablation
8.3.1.2. Radiofrequency Ablation
8.3.1.3. Hydrothermal Ablation
8.3.1.4. Thermal Balloon
8.3.1.5. Microwave Energy
8.3.2. Procedures
8.4. Market Attractiveness Analysis By Type Technique
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By End-User, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-User, 2023 to 2033
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Ambulatory Surgery Centers
9.4. Market Attractiveness Analysis By End-User
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022
10.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
11.4.1. By Country
11.4.1.1. USA
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Type Technique
11.4.3. By End-User
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Type Technique
11.5.3. By End-User
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Type Technique
12.4.3. By End-User
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Type Technique
12.5.3. By End-User
13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. Germany13.4.1.2. France
13.4.1.2. United kingdom
13.4.1.3. Italy
13.4.1.4. Benelux
13.4.1.5. Nordic Countries
13.4.1.6. Rest of Europe
13.4.2. By Type Technique
13.4.3. By End-User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Type Technique
13.5.3. By End-User
14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Type Technique
14.4.3. By End-User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Type Technique
14.5.3. By End-User
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Type Technique
15.4.3. By End-User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Type Technique
15.5.3. By End-User
16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.2.2.1. By Type Technique
16.2.2.2. By End-User
16.3. Canada Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.3.2.1. By Type Technique
16.3.2.2. By End-User
16.4. Mexico Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.4.2.1. By Type Technique
16.4.2.2. By End-User
16.5. Brazil Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.5.2.1. By Type Technique
16.5.2.2. By End-User
16.6. Germany Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.6.2.1. By Type Technique
16.6.2.2. By End-User
16.7. France Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.7.2.1. By Type Technique
16.7.2.2. By End-User
16.8. Italy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.8.2.1. By Type Technique
16.8.2.2. By End-User
16.9. BENELUX Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.9.2.1. By Type Technique
16.9.2.2. By End-User
16.10. UK Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.10.2.1. By Type Technique
16.10.2.2. By End-User
16.11. Nordic Countries Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.11.2.1. By Type Technique
16.11.2.2. By End-User
16.12. China Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.12.2.1. By Type Technique
16.12.2.2. By End-User
16.13. Japan Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.13.2.1. By Type Technique
16.13.2.2. By End-User
16.14. South Korea Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.14.2.1. By Type Technique
16.14.2.2. By End-User
16.15. GCC Countries Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.15.2.1. By Type Technique
16.15.2.2. By End-User
16.16. South Africa Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.16.2.1. By Type Technique
16.16.2.2. By End-User
16.17. Turkey Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.17.2.1. By Type Technique
16.17.2.2. By End-User
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Medtronic
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. CooperSurgical Inc.
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. Boston Scientific Corp.
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Ethicon Inc. (Johnson & Johnson)
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. Olympus Corp.
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. AngioDynamics
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. Hologic Inc.
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
18.3.8. Minerva Surgical
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Strategy Overview
18.3.9. Richard Wolf GmbH
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Endometrial Ablation Market
